371
Participants
Start Date
June 7, 2017
Primary Completion Date
January 25, 2018
Study Completion Date
March 7, 2018
KW-136 capsule
KW-136 60 mg was provided in a single capsule of 60 mg.
Sofosbuvir
Sofosbuvir was provided in a single tablet of 400 mg.
Chinese PLA 302 Hospital, Beijing
Capital Medical University Affiliated Beijing Youyi Hospital, Beijing
Capital Medical University Affiliated Beijing You'an Hospital, Beijing
Capital Medical University Affiliated Beijing Ditan Hospital, Beijing
Shenyang Municipal Sixth People's Hospital, Shenyang
Jilin University First Hospital, Changchun
Yanbian University Affiliated Hosptial, Yanbian
Nanjing Municipal Second Hospital, Nanjing
Ji'nan Municipal Hospital of Infectious Disease, Ji'nan
Chinese PLA Third Military Medical University First Affiliated Hospital, Chongqing
Chongqing Sanxia Central Hospital, Wanzhou
Huazhong University of Science and Technology Affiliated Tongji Hospital, Wuhan
He'nan Provincial Hospital of Infectious Disease (Zhengzhou Municipal Sixth People's Hospital), Zhengzhou
Guangzhou Municipal Eighth People's Hospital, Guanzhou
Sun Yat-sen University Affiliated Third University, Guangzhou
Liuzhou People's Hospital, Liuzhou
Sichuan Provincial People's Hospital, Chengdu
Chinese PLA Fourth Military Medical University Tangdu Hospital, Xi'an
Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Ürümqi
KawinGreen Biotech Co., Ltd.
UNKNOWN
Kawin Technology Share-holding Co., Ltd.
INDUSTRY